Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Thomas W. Loew"'
Autor:
Jason E. Farrar, Anupama Narla, Kelly Walkovich, Helge Hartung, Grzegorz Nalepa, Adrianna Vlachos, Evangelia Atsidaftos, Jeffrey M. Lipton, Mohammad Lutfi Lababidi, Jonathan Bernstein, Ellen Muir, Zora R. Rogers, Thomas W. Loew, Waseem Alhushki, Colin A. Sieff, Bertil Glader, Barbara Gruner, Christine M. Knoll, Arun R Panigrahi
Publikováno v:
Pediatr Blood Cancer
Background Diamond-Blackfan anemia (DBA) is an inherited bone marrow failure syndrome characterized by anemia, short stature, congenital anomalies, and cancer predisposition. Most cases are due to mutations in genes encoding ribosomal proteins (RP) l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f35da0422ca685604b2d6c0cfaafb63
https://europepmc.org/articles/PMC8273758/
https://europepmc.org/articles/PMC8273758/
Autor:
Anthony Thompson, Sharon E. Straus, Clay Hollenback, Frederick D. Goldman, Zuhair K. Ballas, Kejing Song, Jennifer M. Puck, Rajeev Vibhakar, Robert T. Cook, Thomas W. Loew
Publikováno v:
Clinical Immunology. 104:31-39
Autoimmune Lymphoproliferative Syndrome (ALPS) is a disorder of defective lymphocyte apoptosis due to mutations of the Fas receptor and other molecules in the Fas signaling pathway. In addition to accumulation of CD4(-) CD8(-) double-negative (DN) T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05d0ab341db636c1a043b3424a361bed
https://doi.org/10.1006/clim.2002.5249
https://doi.org/10.1006/clim.2002.5249
Autor:
Abbey Elsbernd, Tarris D. Rosell, Kirsten A Boisen, Thomas W. Loew, Christopher Crenner, Maiken Hjerming, Jyoti Panicker, Hanne Bækgaard Larsen
Publikováno v:
Journal of Clinical Oncology. 35:186-186
186 Background: Adolescent and Young Adult (AYA) Oncology is a developing field of medicine with unique challenges in the clinical setting. People at this stage of life face many difficulties, which may be compounded by lack of insurance coverage and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8fe511e133adc963488164906e1c9eb6
https://doi.org/10.1200/jco.2017.35.31_suppl.186
https://doi.org/10.1200/jco.2017.35.31_suppl.186
Autor:
Franklin O. Smith, Lois Hathaway, Joanne M. Hilden, Robert B. Gerbing, Todd A. Alonzo, Jeffrey W. Taub, Alan S. Gamis, Dorothy R. Barnard, April D. Sorrell, Robert J. Arceci, William G. Woods, Thomas W. Loew, Yaddanapudi Ravindranath
Publikováno v:
Cancer. 118(19)
BACKGROUND: Children who are treated for myeloid leukemia associated with Down syndrome (DS) experience superior survival compared with children who have myeloid leukemia without DS. To maintain excellent outcomes while avoiding toxicity, the Childre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f75120a2b7d5be63ff3a275413ad9ca2
https://pubmed.ncbi.nlm.nih.gov/22392565
https://pubmed.ncbi.nlm.nih.gov/22392565
Autor:
Mukta Sharma, Joanne M. Hilden, Thomas W. Loew, Todd A. Alonzo, Jeffrey W. Taub, John Doyle, Alan S. Gamis, Robert B. Gerbing, Franklin O. Smith, Gita Massey, Dorothy R. Barnard, John P. Perentesis, Robert J. Arceci, April D. Sorrell, Yaddanapudi Ravindranath
Publikováno v:
Blood. 118(26)
Transient myeloproliferative disorder (TMD), restricted to newborns with trisomy 21, is a megakaryocytic leukemia that although lethal in some is distinguished by its spontaneous resolution. Later development of acute myeloid leukemia (AML) occurs in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b219f787b440f019c75402524ddc8077
https://pubmed.ncbi.nlm.nih.gov/22194390
https://pubmed.ncbi.nlm.nih.gov/22194390
Autor:
Nathalie Guffon, Joel Charrow, William R. Wilcox, Maryam Banikazemi, Dominique P. Germain, Stephen Waldek, Thomas W. Loew, David A. Bushinsky, Anouk C. Vedder, Rekha Abichandani, Robert J. Desnick, Philip J. Lee
Publikováno v:
Journal of the American Society of Nephrology, 18(5), 1547-1557. American Society of Nephrology
Fabry disease, an inherited deficiency of the lysosomal enzyme alpha-galactosidase A, causes progressive intralysosomal accumulation of globotriaosylceramide (GL-3) and premature death from renal, cardiac, and cerebrovascular manifestations. To deter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e961a66a8a4e49fffc934208daf5981a
https://pure.amc.nl/en/publications/sustained-longterm-renal-stabilization-after-54-months-of-agalsidase-beta-therapy-in-patients-with-fabry-disease(277e4a2f-b040-4367-b93e-aab2c300919b).html
https://pure.amc.nl/en/publications/sustained-longterm-renal-stabilization-after-54-months-of-agalsidase-beta-therapy-in-patients-with-fabry-disease(277e4a2f-b040-4367-b93e-aab2c300919b).html
Autor:
Arnold C. Paulino, Thomas W. Loew, Frederick D. Goldman, Nina A. Mayr, Sanford L. Meeks, John M. Buatti, Timothy C. Ryken, B. Chen Wen, Raymond Tannous
Publikováno v:
American journal of clinical oncology. 26(1)
From 1970 to 1997, 63 patients with medulloblastoma were treated with craniospinal irradiation followed by a posterior fossa boost. There were 38 males and 25 females with a median age of 9 years (range, 8 months to 53 years). Stage was T1-T3a in 50
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4f1360a1b1a9f5bff6fdf072a53a4df
https://pubmed.ncbi.nlm.nih.gov/12576926
https://pubmed.ncbi.nlm.nih.gov/12576926
Publikováno v:
Clinical Case Reports
Key Clinical Message Haematopoietic abnormalities associated with tacrolimus are relatively rare with reversible pure red cell aplasia being the most common. We report for the first time, to our best knowledge, tacrolimus therapy associated with bone
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7dd84d7b46c5d7bda0bdb55caaedc468
https://doi.org/10.1093/ajcp/142.suppl1.116
https://doi.org/10.1093/ajcp/142.suppl1.116
Autor:
Alan S. Gamis, Lois Hathaway, Todd A. Alonzo, Robert J. Arceci, Jeffrey W. Taub, Loris McGavran, Joanne M. Hilden, Yaddanapudi Ravindranath, Franklin O. Smith, Thomas W. Loew, Dorothy R. Barnard, Robert B. Gerbing
Publikováno v:
Blood. 108:15-15
DS children with AML have a superior outcome as compared to nonDS children with AML. For COG A2971, etoposide, dexamethasone, & the 3 month maintenance course from the standard timing DCTER regimen used in the prior CCG 2891 trial, were eliminated. F
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a7bf6552656fa4338286812bdcd16720
https://doi.org/10.1182/blood.v108.11.15.15
https://doi.org/10.1182/blood.v108.11.15.15
Autor:
Myron Chang, William G. Woods, Beverly J. Lange, Robert B. Gerbing, Todd A. Alonzo, Gita Massey, Franklin O. Smith, Joanne M. Hilden, Alan S. Gamis, Thomas W. Loew
Publikováno v:
Blood. 104:4527-4527
Down Syndrome (DS) is known to increase the risk of acute myelogenous leukemia. Recent cooperative group clinical trials, POG 9421 and CCG 2891, using standard timing and cytarabine/daunomycin based chemotherapy achieved induction rates of 95% and 91
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::80067238f998af9546b03de37d085b26
https://doi.org/10.1182/blood.v104.11.4527.4527
https://doi.org/10.1182/blood.v104.11.4527.4527